Your browser doesn't support javascript.
loading
Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins.
Bulanova, Daria; Ianevski, Aleksandr; Bugai, Andrii; Akimov, Yevhen; Kuivanen, Suvi; Paavilainen, Henrik; Kakkola, Laura; Nandania, Jatin; Turunen, Laura; Ohman, Tiina; Ala-Hongisto, Hanna; Pesonen, Hanna M; Kuisma, Marika S; Honkimaa, Anni; Walton, Emma L; Oksenych, Valentyn; Lorey, Martina B; Guschin, Dmitry; Shim, Jungmin; Kim, Jinhee; Than, Thoa T; Chang, So Young; Hukkanen, Veijo; Kulesskiy, Evgeny; Marjomaki, Varpu S; Julkunen, Ilkka; Nyman, Tuula A; Matikainen, Sampsa; Saarela, Jani S; Sane, Famara; Hober, Didier; Gabriel, Gülsah; De Brabander, Jef K; Martikainen, Miika; Windisch, Marc P; Min, Ji-Young; Bruzzone, Roberto; Aittokallio, Tero; Vähä-Koskela, Markus; Vapalahti, Olli; Pulk, Arto; Velagapudi, Vidya; Kainov, Denis E.
Afiliação
  • Bulanova D; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki 00290, Finland. daria.bulanova@helsinki.fi.
  • Ianevski A; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki 00290, Finland. aleksandr.ianevski@helsinki.fi.
  • Bugai A; Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki 00290, Finland. andrii.bugai@helsinki.fi.
  • Akimov Y; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki 00290, Finland. yevhen.akimov@helsinki.fi.
  • Kuivanen S; Department of Virology, University of Helsinki, Helsinki 00290, Finland. suvi.kuivanen@helsinki.fi.
  • Paavilainen H; Department of Virology, University of Turku, Turku 20520, Finland. hojpaa@utu.fi.
  • Kakkola L; Department of Virology, University of Turku, Turku 20520, Finland. laura.kakkola@utu.fi.
  • Nandania J; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki 00290, Finland. jatin.nandania@helsinki.fi.
  • Turunen L; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki 00290, Finland. laura.turunen@helsinki.fi.
  • Ohman T; Institute of Biotechnology, University of Helsinki, Helsinki 00014, Finland. tiina.ohman@helsinki.fi.
  • Ala-Hongisto H; Biomedicum Functional Genomics Unit (FuGU), Helsinki, Helsinki 00290, Finland. hanna.ala-hongisto@helsinki.fi.
  • Pesonen HM; Biomedicum Functional Genomics Unit (FuGU), Helsinki, Helsinki 00290, Finland. hanna.m.pesonen@helsinki.fi.
  • Kuisma MS; Biomedicum Functional Genomics Unit (FuGU), Helsinki, Helsinki 00290, Finland. marika.kuisma@helsinki.fi.
  • Honkimaa A; Department of Virology, University of Tampere, Tampere 33520, Finland. Anni.Honkimaa@uta.fi.
  • Walton EL; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7028, Norway. emma.l.walton@ntnu.no.
  • Oksenych V; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7028, Norway. valentyn.oksenych@ntnu.no.
  • Lorey MB; University of Helsinki and Helsinki University Hospital, Rheumatology, Helsinki 00290, Finland. martina.lorey@helsinki.fi.
  • Guschin D; Institut Pasteur Korea, Gyeonggi-do 13488, Korea. albanec2@gmail.com.
  • Shim J; Institut Pasteur Korea, Gyeonggi-do 13488, Korea. jungmin.shim@ip-korea.org.
  • Kim J; Institut Pasteur Korea, Gyeonggi-do 13488, Korea. jinhee.kim@ip-korea.org.
  • Than TT; Institut Pasteur Korea, Gyeonggi-do 13488, Korea. thoa.than@ip-korea.org.
  • Chang SY; Institut Pasteur Korea, Gyeonggi-do 13488, Korea. soyoung.chang@ip-korea.org.
  • Hukkanen V; Department of Virology, University of Turku, Turku 20520, Finland. veijo.hukkanen@utu.fi.
  • Kulesskiy E; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki 00290, Finland. evgeny.kulesskiy@helsinki.fi.
  • Marjomaki VS; Department of Biological and Environmental Science/Nanoscience center, University of Jyväskylä, Jyväskylä 40500, Finland. varpu.s.marjomaki@jyu.fi.
  • Julkunen I; Department of Virology, University of Turku, Turku 20520, Finland. ilkka.julkunen@utu.fi.
  • Nyman TA; Institute of Biotechnology, University of Helsinki, Helsinki 00014, Finland. t.a.nyman@medisin.uio.no.
  • Matikainen S; Department of Immunology, University of Oslo, Oslo 0424, Norway. t.a.nyman@medisin.uio.no.
  • Saarela JS; University of Helsinki and Helsinki University Hospital, Rheumatology, Helsinki 00290, Finland. sampsa.matikainen@helsinki.fi.
  • Sane F; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki 00290, Finland. jani.saarela@helsinki.fi.
  • Hober D; University of Lille, CHU Lille laboratoire de Virologie, EA3610, F-59037 Lille, France. famara.sane@chru-lille.fr.
  • Gabriel G; University of Lille, CHU Lille laboratoire de Virologie, EA3610, F-59037 Lille, France. didier.hober@chru-lille.fr.
  • De Brabander JK; Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg 20251, Germany. guelsah.gabriel@hpi.uni-hamburg.de.
  • Martikainen M; Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9038, USA. jef.debrabander@utsouthwestern.edu.
  • Windisch MP; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala 75237, Sweden. miika.martikainen@igp.uu.se.
  • Min JY; Institut Pasteur Korea, Gyeonggi-do 13488, Korea. marc.windisch@ip-korea.org.
  • Bruzzone R; Institut Pasteur Korea, Gyeonggi-do 13488, Korea. jiyoung.min@ip-korea.org.
  • Aittokallio T; Institut Pasteur Korea, Gyeonggi-do 13488, Korea. bruzzone@hkucc.hku.hk.
  • Vähä-Koskela M; HKU-Pasteur Research Pole, School of Public Health, University of Hong Kong, Hong Kong, China. bruzzone@hkucc.hku.hk.
  • Vapalahti O; Department of Cell Biology and Infection, Institut Pasteur, Paris 75015, France. bruzzone@hkucc.hku.hk.
  • Pulk A; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki 00290, Finland. tero.aittokallio@helsinki.fi.
  • Velagapudi V; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki 00290, Finland. markus.vaha-koskela@helsinki.fi.
  • Kainov DE; Department of Virology and Immunology, University of Helsinki and Helsinki University Hospital, Helsinki 00014, Finland. olli.vapalahti@helsinki.fi.
Viruses ; 9(10)2017 09 25.
Article em En | MEDLINE | ID: mdl-28946654
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Replicação Viral / Vírus / Apoptose / Proteínas Proto-Oncogênicas c-bcl-2 / Benzotiazóis / Isoquinolinas Limite: Humans Idioma: En Revista: Viruses Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Replicação Viral / Vírus / Apoptose / Proteínas Proto-Oncogênicas c-bcl-2 / Benzotiazóis / Isoquinolinas Limite: Humans Idioma: En Revista: Viruses Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Suíça